Goldman Sachs Ups PT On AET To $61

Goldman Sachs has raised its price target $2 on Aetna AET, from $59 to $61 in light of 2Q numbers reported by the company. According to Goldman Sachs, “Following 2Q, we increase our 2011 EPS by $0.20, to $4.70, the high-end of Aetna's new range of $4.60-$4.70 that the company increased $0.40 from its prior outlook. We also increase our 2012 EPS to $5.20 (from $5.10) and our 2013 EPS to $5.80 from $5.75 to reflect the stronger growth outlook.” Goldman Sachs maintains its Buy rating on the stock. AET closed yesterday at $41.72.